Navigation Links
National Quality Forum Endorses Six Measures for Melanoma and Eye Care
Date:11/5/2009

WASHINGTON, Nov. 5 /PRNewswire-USNewswire/ -- The National Quality Forum (NQF) has endorsed six measures to improve quality of eye and skin care in the ambulatory setting. The endorsed measures address melanoma and eye care, specifically glaucoma, macular degeneration, and cataracts.

Melanoma. The American Cancer Society estimates that about 68,720 new melanomas will be diagnosed in the United States during 2009. Although melanoma accounts for less than five percent of skin cancer cases, it causes a large majority of skin cancer deaths. The first new NQF-endorsed(R) standard for melanoma focuses on coordination of care and is intended to measure the clinician managing the melanoma, regardless of specialty. This standard aligns with the National Priorities Partnership's priority of improving care coordination. The second new NQF-endorsed standard for melanoma aligns with the National Priority of reducing overuse, targeting appropriate use of diagnostic imaging studies. The measure developer noted that melanoma care costs $240 million year, and as much as 50 percent is related to routine imaging ordered by a host of providers, including dermatologist and primary care physicians.

Eye care. The new NQF-endorsed standards for cataracts focus on complications and visual acuity following cataract surgery. According to the National Eye Institute and Prevent Blindness America (2002), cataracts affect nearly 20.5 million Americans age 40 and older. Other new NQF-endorsed standards for eye care address counseling for age-related macular degeneration, which is anticipated to affect almost 3 million people in the United States by 2020, and treatment and plan of care for glaucoma, the leading cause of blindness among African-Americans.

NQF's steering committee on eye care and melanoma measures in the ambulatory setting was co-chaired by Jeffery Kang, senior vice president, clinical programs and policy at CIGNA, and Alice Stollenwerk Petrulis, chief medical officer at KePRO.

NQF is a voluntary consensus standards-setting organization. Any party may request reconsideration of the recommendations, in whole or in part, by notifying NQF in writing via e-mail no later than December 4 (appeals@qualityforum.org). For an appeal to be considered, the notification e-mail must include information clearly demonstrating that the appellant has interests that are directly and materially affected by the NQF-endorsed recommendations and that the NQF decision has had (or will have) an adverse effect on those interests.

The mission of the National Quality Forum is to improve the quality of American healthcare by setting national priorities and goals for performance improvement, endorsing national consensus standards for measuring and publicly reporting on performance, and promoting the attainment of national goals through education and outreach programs. NQF, a non-profit organization (www.qualityforum.org) with diverse stakeholders across the public and private health sectors, was established in 1999 and is based in Washington, DC.

SOURCE National Quality Forum


'/>"/>
SOURCE National Quality Forum
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... PRUSSIA, PA and LONDON, UK (PRWEB) , ... May 06, 2016 ... ... earn accolades for his success in changing the way the pharmaceutical industry conducts clinical ... list of the world’s most influential people in pharma, and he was honored as ...
(Date:5/6/2016)... ... May 06, 2016 , ... US Sports Camps has collaborated with State Rugby ... State University this summer. Employing world-class rugby figures, including former Team USA players and ... training on key fundamentals, match play, fitness and more. , “US Sports Camps is ...
(Date:5/6/2016)... ... May 06, 2016 , ... Innovations with Ed ... airing third quarter 2016, via Discovery Channel. Dates and show times TBA. , ... optimized drug discovery through innovative cellular analysis. In this segment, viewers will learn ...
(Date:5/6/2016)... ... ... Online HR/benefits platforms offer a range of benefits functions to employers of all ... “ The Rapid Emergence of Online Benefits Firms: Strategies for Health Plans and Brokers ... an accurate picture of online benefits today, and the possible risks and rewards. Featuring ...
(Date:5/6/2016)... ... ... Mark Black is a speaker, author, and life strategy coach who is spreading the ... help of his publisher Strategic Book Group and its subsidiary Publish on Demand Global ... a miracle: He needed a heart and double-lung transplant. From this came a life-changing transformation ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Research and ... Systemic Lupus Erythematosus Market and Competitive Landscape ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Systemic Lupus Erythematosus Market and Competitive Landscape ... Systemic Lupus Erythematosus pipeline products, Systemic Lupus ...
(Date:5/4/2016)... ZIONA, Israel , May 4, 2016 ... BVXV) announced today that BiondVax,s CEO, Dr. Ron Babecoff ... in New York City . ... 10:30am at Pioneers 2016, a conference presented by Joseph ... Palace Hotel. The BiondVax presentation that Dr. Babecoff ...
(Date:5/4/2016)... May 4, 2016 Valeritas Holdings, ... an alternative public offering (APO). This was accomplished via ... Valeritas, Inc. and a private placement of approximately 5 ... per share. Under the terms of the ... Valeritas Holdings, Inc. will trade on the OTC Markets ...
Breaking Medicine Technology: